The firm is a trans-Atlantic venture investment firm focused on building innovative Life Sciences businesses in the UK, Europe and the USA. The firm has a highly experienced team that focuses on turning break-through science into approved medicines or medical products.
The firm starts and invests in early and mid-stage companies with a first-in-class or best-in-class approach. The investments are focused in new drug discovery – small molecules, biologics and new modalities – med tech, enabling technologies and vaccines.
The firm’s team are well connected team and experienced, and the team supports each investment. The firm works in close alignment with management teams, and partners with them to realize their vision and achieve financial returns by bringing innovation to patients.
If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.
Leave a Reply